Relay Therapeutics (RLAY) Treasury Shares (2019 - 2025)
Relay Therapeutics (RLAY) posted quarterly Treasury Shares of $2.4 million for Q4 2025, down 58.39% year-over-year from $5.8 million in Q4 2024, and down 58.39% quarter-over-quarter from $5.8 million in Q4 2024.
Relay Therapeutics (RLAY) Treasury Shares (2019 - 2025) Analysis & Trends
Relay Therapeutics (RLAY) has reported Treasury Shares for 6 consecutive years, with $2.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares fell 58.39% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $2.4 million (down 58.39% YoY), while the FY2025 annual figure was $2.4 million, down 58.39% from the prior year.
- Treasury Shares eased to $2.4 million in Q4 2025 per RLAY's latest filing, from $5.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $5.8 million in Q4 2024 and bottomed at $691205.0 in Q4 2021.
- Historically, Treasury Shares has averaged $2.6 million across 4 years, with a median of $2.0 million in 2022.
- Annual changes were most pronounced in 2021 — Treasury Shares soared 718.1% — and 2025, when it plunged 58.39%.
- Relay Therapeutics' Treasury Shares stood at $691205.0 in 2021, then surged by 126.67% to $1.6 million in 2022, then soared by 270.74% to $5.8 million in 2024, then slumped by 58.39% to $2.4 million in 2025.
- Business Quant data shows RLAY's Treasury Shares at $2.4 million in Q4 2025, $5.8 million in Q4 2024, and $1.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 691,205.00 |
| Dec 31, 2021 | 691,205.00 |
| Dec 31, 2020 | 84,489.00 |
| Dec 31, 2020 | 84,489.00 |
| Sep 30, 2020 | 173,818.00 |
| Sep 30, 2020 | 173,818.00 |
| Jun 30, 2020 | 212.64 Mn |
| Jun 30, 2020 | 212.64 Mn |
| Dec 31, 2019 | 212.64 Mn |
| Dec 31, 2019 | 212.64 Mn |